Oliver Zielinski selected as Fellow of The Oceanography Society
Grant and Award Announcement
This month, we’re focusing on artificial intelligence (AI), a topic that continues to capture attention everywhere. Here, you’ll find the latest research news, insights, and discoveries shaping how AI is being developed and used across the world.
Updates every hour. Last Updated: 29-Apr-2026 00:16 ET (29-Apr-2026 04:16 GMT/UTC)
Scientists at the Max Planck Institute for Intelligent Systems, Hong Kong University of Science and Technology and Koç University in Istanbul have created hydrogel-based artificial cilia that move almost exactly like real biological cilia – the closest imitation achieved so far. The researchers can program each micrometer-sized cilium to move freely in space – just like cilia in the human body. With their research, the scientists aim to investigate how natural cilia function, how they coordinate their movement, and what role they play in brain development, signal perception, and fluid movement, for example. Because the artificial cilia are soft and easy to control, they could one day be used in medical devices to help people whose natural cilia are damaged or not working properly. The fast, low-voltage motion demonstrated in their study could also inspire a new generation of tiny robots that were previously impossible at such small scales. This milestone work will be published in Nature on January 14, 2026.
Bonn, January 14, 2026 – Researchers from Bonn and Basel have developed a new method to equip human retinal organoids – small, lab-grown models of the retina – with artificial blood vessel structures. These vascularized retinal organoids, called vROs, preserve inner retinal cell types and for the first time, form fully functional light-signal pathways from photoreceptors to retinal ganglion cells.
Cambridge, Massachusetts, January 14, 2025 - Insilico Medicine (“Insilico”, HKEX:03696), a clinical-stage biotechnology company driven by generative artificial intelligence (AI), today announced the demonstration of its Nach01 multimodal foundation model deployed on Microsoft Discovery, Microsoft’s science-focused platform designed to accelerate research and development through agentic AI. This collaboration highlights Microsoft Discovery’s extensibility with third-party AI models and illustrates how R&D organizations can adopt unified, AI-native workflows for computational drug discovery. By orchestrating secure, multi-step investigations within a Microsoft Azure-native environment, the demonstration underscores key benefits—including enhanced transparency, improved reproducibility, and scalable deployment—empowering scientific teams to streamline and advance discovery processes with great assurance.
During the World Economic Forum (WEF) in Davos on 19–23 January 2026, Chalmers University of Technology, Sweden participates in Science House – an international meeting place for science, innovation and sustainable societal development. We invite journalists to find out about the latest advanced of the world’s strongest battery, and to interview the researcher who thinks that technologies such as AI isn’t “stealing” human jobs – but something we need to address Europe’s imminent skill shortage.